Skip to Content

CTI 103 (Diclofenac Sodium Delayed Release 75 mg)

Pill with imprint CTI 103 is White, Round and has been identified as Diclofenac Sodium Delayed Release 75 mg. It is supplied by Carlsbad Technology, Inc..

Diclofenac is used in the treatment of back pain; frozen shoulder; ankylosing spondylitis; aseptic necrosis; migraine and belongs to the drug class Nonsteroidal anti-inflammatory drugs. There is positive evidence of human fetal risk during pregnancy. Diclofenac 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CTI 103

Diclofenac sodium delayed release 75 mg CTI 103
Diclofenac sodium delayed release 75 mg CTI 103
Diclofenac sodium delayed release 75 mg CTI 103
Diclofenac sodium delayed release 75 mg CTI 103

Diclofenac Sodium Delayed Release

Imprint
CTI 103
Strength
75 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Carlsbad Technology, Inc.
Inactive Ingredients
ferrosoferric oxide, hypromelloses, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:1), microcrystalline cellulose, shellac, polyethylene glycol 2000, povidone, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
61442-0103 Carlsbad Technology, Inc.
42291-0231 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.